MedTrace Logo

Testing the Nocturnal Sleep Latency Profile in Primary Insomnia

NCT00167375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2008-02-15

No results posted yet for this study

Summary

This study tests a new kind of sleep study in which subjects are awakened 2 times after initially going to sleep. The study focuses on the EEG signal process as a person goes to sleep. The general hypothesis is that the signal properties are stable from night to night during baseline studies, and are different between controls and patients with primary insomnia. The primary insomnia patients then go on to have about 2 weeks of an insomnia intervention. Then the new kind of study is repeated in the patients. The controls only are examined in baseline studies.

Conditions

  • Primary Insomnia
  • Sleep Initiation and Maintenance Disorders

Interventions

DRUG

eszopiclone 3 mg qHS

BEHAVIORAL

General cognitive/behavioral interventions for insomnia

Sponsors & Collaborators

  • American Academy of Sleep Medicine

    collaborator OTHER

  • Sumitomo Pharma America, Inc.

    collaborator INDUSTRY

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Douglas E Moul, M.D., M.P.H · University of Pittsburgh

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-01-31
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00167375 on ClinicalTrials.gov